NB
Nishant Bhasin
About Nishant Bhasin
Data last updated:
Nishant Bhasin is a Director at Aakash Medicines Private Limited (since 2023). The companies operate in Consumer Products and Infrastructure and Utilities. Aakash Medicines Private Limited reported revenue of ₹3.24 Cr (FY 2025). Earlier, Nishant Bhasin was a Designated Partner at Tranz Rail Solutions Limited Liability Partnership (2018).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Aakash Medicines Private Limited U47721DL2023PTC414085 | Director | 28 Aug 2023 | 2023 | ₹3.24 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 30 Jan 2018 | 2018 | ₹5.18 Cr (FY 2023) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nishant Bhasin
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aakash Chaudhry | 00106392 | Aakash Medicines Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nishant Bhasin
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nishant Bhasin
Nishant Bhasin currently holds 1 directorship: Aakash Medicines Private Limited (Director, since 28 Aug 2023, revenue ₹3.24 Cr (FY 2025)).
Nishant Bhasin was first appointed on 30 Jan 2018 as Designated Partner at Tranz Rail Solutions Limited Liability Partnership. The most recent appointment on record is 28 Aug 2023 at Aakash Medicines Private Limited.
Nishant Bhasin held 1 earlier board appointment: Tranz Rail Solutions Limited Liability Partnership (Designated Partner, 30 Jan 2018 to 24 Sep 2018).
The current boards of Nishant Bhasin's companies include Aakash Chaudhry (Aakash Medicines Private Limited).